Mark your calendars for the All-Inclusive Topical Drug Bioequivalence and Bioavailability Summit, co-sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation and the American Association of Pharmaceutical Scientists.
About the Event:
The All-Inclusive Topical Drug Bioequivalence and Bioavailability Summit will be held on Tuesday, May 21, 2013, at the University of Maryland School of Pharmacy, located at 20 North Pine Street in Baltimore, MD.
This summit, co-sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI) and the American Association of Pharmaceutical Scientists (AAPS), is a one-day conference that is open to the public. Its goal is to address methods for evaluating topical drug bioavailability and bioequivalence, as well as follow up on the results from the Product Quality Research Institute (PQRI) workshop held at the US Pharmacopeia Meeting Center in Rockville, MD, on March 11-13, 2013.
About the Sponsors:
 |
Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific association of approximately 12,000 members employed in industry, academia, government, and other research institutes worldwide. |
 |
The Center of Excellence in Regulatory Science and Innovation (CERSI) focuses on modernizing and improving the ways in which drugs and medical devices are developed and evaluated. It is a collaborative partnership between the Food and Drug Administration (FDA) and the Baltimore and College Park campuses of the University of Maryland. |
For More Information:
More information, including registration, agenda, accommodations, and parking and directions, can be found on this website.